Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 244.19 INR -4.45% Market Closed
Market Cap: 22.5B INR

Intrinsic Value

The intrinsic value of one INDOCO stock under the Base Case scenario is 344.73 INR. Compared to the current market price of 244.19 INR, Indoco Remedies Ltd is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INDOCO Intrinsic Value
344.73 INR
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Indoco Remedies Ltd

INDOCO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for INDOCO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Indoco Remedies Ltd
NSE:INDOCO
IN
Pharmaceuticals
Market Cap
22.5B INR
IPO
Jan 7, 2005
IN
Pharmaceuticals
Market Cap
22.5B INR
IPO
Jan 7, 2005
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INDOCO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Indoco Remedies Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Indoco Remedies Ltd

Current Assets 10.3B
Cash & Short-Term Investments 445m
Receivables 3.9B
Other Current Assets 6B
Non-Current Assets 13.6B
Long-Term Investments 84.2m
PP&E 10.3B
Intangibles 1.9B
Other Non-Current Assets 1.3B
Efficiency

Free Cash Flow Analysis
Indoco Remedies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Indoco Remedies Ltd

Revenue
17.2B INR
Cost of Revenue
-5.3B INR
Gross Profit
11.9B INR
Operating Expenses
-11.5B INR
Operating Income
376.4m INR
Other Expenses
-482.9m INR
Net Income
-106.5m INR
Fundamental Scores

INDOCO Profitability Score
Profitability Due Diligence

Indoco Remedies Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
46/100
Profitability
Score

Indoco Remedies Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

INDOCO Solvency Score
Solvency Due Diligence

Indoco Remedies Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
41/100
Solvency
Score

Indoco Remedies Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INDOCO Price Targets Summary
Indoco Remedies Ltd

Wall Street analysts forecast INDOCO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INDOCO is 321.3 INR with a low forecast of 297.95 INR and a high forecast of 341.25 INR.

Lowest
Price Target
297.95 INR
22% Upside
Average
Price Target
321.3 INR
32% Upside
Highest
Price Target
341.25 INR
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for INDOCO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

INDOCO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one INDOCO stock?

The intrinsic value of one INDOCO stock under the Base Case scenario is 344.73 INR.

Is INDOCO stock undervalued or overvalued?

Compared to the current market price of 244.19 INR, Indoco Remedies Ltd is Undervalued by 29%.

Back to Top